Large-scale testing (Phase 3)Study completedNCT02269475
What this trial is testing
A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 Years
Who this might be right for
Healthy Japanese Children Age 7 Years Through 18 Years
AstraZeneca 1,369